SidaSubSaharaV1, Main, Exploration, bibRecord, 006348

Low Prevalence of Detectable HIV Plasma Viremia in Patients Treated With Antiretroviral Therapy in Burkina Faso and Mali

Identifieur interne : 006348 ( Main/Exploration ); précédent : 006347; suivant : 006349

Low Prevalence of Detectable HIV Plasma Viremia in Patients Treated With Antiretroviral Therapy in Burkina Faso and Mali

Auteurs : Catherine Boileau [Canada] ; Vinh-Kim Nguyen [Canada] ; Mohamed Sylla [Canada] ; Nima Machouf [Canada] ; Annie Chamberland [Canada] ; Hamar A. Traore [Mali] ; Pascal A. Niamba [Burkina Faso] ; Ismaël Diallo [Burkina Faso] ; Moussa Maiga [Mali] ; Mamadou Cisse [Mali] ; Sélim Rashed [Canada] ; Cécile Tremblay [Canada]

Source :

Journal of acquired immune deficiency syndromes : (1999) [ 1525-4135 ] ; 2008.

RBID : Pascal:08-0387823

Descripteurs français

Pascal (Inist)
- Prévalence, Epidémiologie, Antiviral, Chimiothérapie, Burkina, Mali, Charge virale, Antirétroviral, SIDA, Virémie, Afrique subsaharienne, Suppression, Microbiologie, Virologie.
Wicri :
- geographic : Mali.

English descriptors

KwdEn :
- AIDS, Antiretroviral agent, Antiviral, Burkina Faso, Chemotherapy, Epidemiology, Mali, Microbiology, Prevalence, Sub-Saharan Africa, Suppression, Viral load, Viremia, Virology.

Abstract

Background: Sub-Saharan Africa has seen dramatic increases in the numbers of people treated with antiretroviral therapy (ART). Although standard ART regimens are now universally applied, viral load measurement is not currently part of standard monitoring protocols in sub-Saharan Africa. Methods: We describe the prevalence of inadequate virological response (IVR) to ART (viral load ≥ 500 copies/mL) and identify factors associated with this outcome in 606 HIV-positive patients treated for at least 6 months. Recruitment took place in 7 hospitals and community-based sites in Bamako and Ouagadougou, and information was collected using medical charts and interviews. Results: The overall prevalence of IVR in treatment-naive patients was 12.3% and 24.4% for pretreated patients. There were no differences in rates of IVR according to ART delivery sites and time on treatment. Patients living farther away [odds ratio (OR) = 2.48; 95% confidence interval (CI) 1.40 to 4.39], those on protease inhibitor or nucleoside reverse transcriptase inhibitor regimens (OR = 3.23; 95% CI 1.79 to 5.82) and those reporting treatment interruptions (OR = 2.36; 95% CI 1.35 to 4.15), had increased odds of IVR. Immune suppression (OR = 3.32, 95% CI 1.94 to 5.70) and poor self-rated health (OR = 2.00; 95% CI 1.17 to 3.41) were also associated with IVR. Conclusions: Sufficient expertise and dedication exist in public hospital and community-based programs to achieve rates of treatment success comparable to better-resourced settings.

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 000527
to stream PascalFrancis, to step Curation: 000445
to stream PascalFrancis, to step Checkpoint: 000451
to stream Main, to step Merge: 006446
to stream Main, to step Curation: 006348

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Low Prevalence of Detectable HIV Plasma Viremia in Patients Treated With Antiretroviral Therapy in Burkina Faso and Mali</title>
<author><name sortKey="Boileau, Catherine" sort="Boileau, Catherine" uniqKey="Boileau C" first="Catherine" last="Boileau">Catherine Boileau</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Institute for Health and Social Policy-McGill University</s1>
<s2>Montreal, Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Institute for Health and Social Policy-McGill University</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nguyen, Vinh Kim" sort="Nguyen, Vinh Kim" uniqKey="Nguyen V" first="Vinh-Kim" last="Nguyen">Vinh-Kim Nguyen</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Département de Médecine Sociale et Préventive-Université de Montréal</s1>
<s2>Montreal</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sylla, Mohamed" sort="Sylla, Mohamed" uniqKey="Sylla M" first="Mohamed" last="Sylla">Mohamed Sylla</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Département de Microbiologie et Immunologie-Université de Montréal</s1>
<s2>Montreal</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Machouf, Nima" sort="Machouf, Nima" uniqKey="Machouf N" first="Nima" last="Machouf">Nima Machouf</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Clinique Médicale L'Actuel</s1>
<s2>Montreal, Quebec</s2>
<s3>CAN</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Clinique Médicale L'Actuel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chamberland, Annie" sort="Chamberland, Annie" uniqKey="Chamberland A" first="Annie" last="Chamberland">Annie Chamberland</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Département de Microbiologie et Immunologie-Université de Montréal</s1>
<s2>Montreal</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Traore, Hamar A" sort="Traore, Hamar A" uniqKey="Traore H" first="Hamar A." last="Traore">Hamar A. Traore</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Hôpital National du Point G-Unité de Médecine Interne</s1>
<s2>Bamako</s2>
<s3>MLI</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Mali</country>
<wicri:noRegion>Hôpital National du Point G-Unité de Médecine Interne</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Niamba, Pascal A" sort="Niamba, Pascal A" uniqKey="Niamba P" first="Pascal A." last="Niamba">Pascal A. Niamba</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Centre Universitaire Hospitalier Yalgado-Ouédraogo-Unité de Dermatologie</s1>
<s2>Ouagadougou</s2>
<s3>BFA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Burkina Faso</country>
<wicri:noRegion>Centre Universitaire Hospitalier Yalgado-Ouédraogo-Unité de Dermatologie</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Diallo, Ismael" sort="Diallo, Ismael" uniqKey="Diallo I" first="Ismaël" last="Diallo">Ismaël Diallo</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Centre Universitaire Hospitalier Yalgado-Ouédraogo-Unité de Médecine Interne</s1>
<s2>Ouagadougou</s2>
<s3>BFA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Burkina Faso</country>
<wicri:noRegion>Centre Universitaire Hospitalier Yalgado-Ouédraogo-Unité de Médecine Interne</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Maiga, Moussa" sort="Maiga, Moussa" uniqKey="Maiga M" first="Moussa" last="Maiga">Moussa Maiga</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Hôpital Gabriel Touré</s1>
<s2>Bamako</s2>
<s3>MLI</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Mali</country>
<wicri:noRegion>Hôpital Gabriel Touré</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cisse, Mamadou" sort="Cisse, Mamadou" uniqKey="Cisse M" first="Mamadou" last="Cisse">Mamadou Cisse</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Centre de soins, d'animation et de conseils pour les personnes atteintes du VIH/SIDA (CESAC)</s1>
<s2>Bamako</s2>
<s3>MLI</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Mali</country>
<wicri:noRegion>Bamako</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rashed, Selim" sort="Rashed, Selim" uniqKey="Rashed S" first="Sélim" last="Rashed">Sélim Rashed</name>
<affiliation wicri:level="3"><inist:fA14 i1="10"><s1>Unité de Santé Internationale-Université de Montréal</s1>
<s2>Montreal</s2>
<s3>CAN</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tremblay, Cecile" sort="Tremblay, Cecile" uniqKey="Tremblay C" first="Cécile" last="Tremblay">Cécile Tremblay</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Département de Microbiologie et Immunologie-Université de Montréal</s1>
<s2>Montreal</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">08-0387823</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 08-0387823 INIST</idno>
<idno type="RBID">Pascal:08-0387823</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000527</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000445</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000451</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000451</idno>
<idno type="wicri:doubleKey">1525-4135:2008:Boileau C:low:prevalence:of</idno>
<idno type="wicri:Area/Main/Merge">006446</idno>
<idno type="wicri:Area/Main/Curation">006348</idno>
<idno type="wicri:Area/Main/Exploration">006348</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Low Prevalence of Detectable HIV Plasma Viremia in Patients Treated With Antiretroviral Therapy in Burkina Faso and Mali</title>
<author><name sortKey="Boileau, Catherine" sort="Boileau, Catherine" uniqKey="Boileau C" first="Catherine" last="Boileau">Catherine Boileau</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Institute for Health and Social Policy-McGill University</s1>
<s2>Montreal, Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Institute for Health and Social Policy-McGill University</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nguyen, Vinh Kim" sort="Nguyen, Vinh Kim" uniqKey="Nguyen V" first="Vinh-Kim" last="Nguyen">Vinh-Kim Nguyen</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Département de Médecine Sociale et Préventive-Université de Montréal</s1>
<s2>Montreal</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sylla, Mohamed" sort="Sylla, Mohamed" uniqKey="Sylla M" first="Mohamed" last="Sylla">Mohamed Sylla</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Département de Microbiologie et Immunologie-Université de Montréal</s1>
<s2>Montreal</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Machouf, Nima" sort="Machouf, Nima" uniqKey="Machouf N" first="Nima" last="Machouf">Nima Machouf</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Clinique Médicale L'Actuel</s1>
<s2>Montreal, Quebec</s2>
<s3>CAN</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Clinique Médicale L'Actuel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chamberland, Annie" sort="Chamberland, Annie" uniqKey="Chamberland A" first="Annie" last="Chamberland">Annie Chamberland</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Département de Microbiologie et Immunologie-Université de Montréal</s1>
<s2>Montreal</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Traore, Hamar A" sort="Traore, Hamar A" uniqKey="Traore H" first="Hamar A." last="Traore">Hamar A. Traore</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Hôpital National du Point G-Unité de Médecine Interne</s1>
<s2>Bamako</s2>
<s3>MLI</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Mali</country>
<wicri:noRegion>Hôpital National du Point G-Unité de Médecine Interne</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Niamba, Pascal A" sort="Niamba, Pascal A" uniqKey="Niamba P" first="Pascal A." last="Niamba">Pascal A. Niamba</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Centre Universitaire Hospitalier Yalgado-Ouédraogo-Unité de Dermatologie</s1>
<s2>Ouagadougou</s2>
<s3>BFA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Burkina Faso</country>
<wicri:noRegion>Centre Universitaire Hospitalier Yalgado-Ouédraogo-Unité de Dermatologie</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Diallo, Ismael" sort="Diallo, Ismael" uniqKey="Diallo I" first="Ismaël" last="Diallo">Ismaël Diallo</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Centre Universitaire Hospitalier Yalgado-Ouédraogo-Unité de Médecine Interne</s1>
<s2>Ouagadougou</s2>
<s3>BFA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Burkina Faso</country>
<wicri:noRegion>Centre Universitaire Hospitalier Yalgado-Ouédraogo-Unité de Médecine Interne</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Maiga, Moussa" sort="Maiga, Moussa" uniqKey="Maiga M" first="Moussa" last="Maiga">Moussa Maiga</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Hôpital Gabriel Touré</s1>
<s2>Bamako</s2>
<s3>MLI</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Mali</country>
<wicri:noRegion>Hôpital Gabriel Touré</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cisse, Mamadou" sort="Cisse, Mamadou" uniqKey="Cisse M" first="Mamadou" last="Cisse">Mamadou Cisse</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Centre de soins, d'animation et de conseils pour les personnes atteintes du VIH/SIDA (CESAC)</s1>
<s2>Bamako</s2>
<s3>MLI</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Mali</country>
<wicri:noRegion>Bamako</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rashed, Selim" sort="Rashed, Selim" uniqKey="Rashed S" first="Sélim" last="Rashed">Sélim Rashed</name>
<affiliation wicri:level="3"><inist:fA14 i1="10"><s1>Unité de Santé Internationale-Université de Montréal</s1>
<s2>Montreal</s2>
<s3>CAN</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tremblay, Cecile" sort="Tremblay, Cecile" uniqKey="Tremblay C" first="Cécile" last="Tremblay">Cécile Tremblay</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Département de Microbiologie et Immunologie-Université de Montréal</s1>
<s2>Montreal</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of acquired immune deficiency syndromes : (1999)</title>
<title level="j" type="abbreviated">J. acquir. immune defic. syndr. : (1999)</title>
<idno type="ISSN">1525-4135</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of acquired immune deficiency syndromes : (1999)</title>
<title level="j" type="abbreviated">J. acquir. immune defic. syndr. : (1999)</title>
<idno type="ISSN">1525-4135</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS</term>
<term>Antiretroviral agent</term>
<term>Antiviral</term>
<term>Burkina Faso</term>
<term>Chemotherapy</term>
<term>Epidemiology</term>
<term>Mali</term>
<term>Microbiology</term>
<term>Prevalence</term>
<term>Sub-Saharan Africa</term>
<term>Suppression</term>
<term>Viral load</term>
<term>Viremia</term>
<term>Virology</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Prévalence</term>
<term>Epidémiologie</term>
<term>Antiviral</term>
<term>Chimiothérapie</term>
<term>Burkina</term>
<term>Mali</term>
<term>Charge virale</term>
<term>Antirétroviral</term>
<term>SIDA</term>
<term>Virémie</term>
<term>Afrique subsaharienne</term>
<term>Suppression</term>
<term>Microbiologie</term>
<term>Virologie</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Mali</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background: Sub-Saharan Africa has seen dramatic increases in the numbers of people treated with antiretroviral therapy (ART). Although standard ART regimens are now universally applied, viral load measurement is not currently part of standard monitoring protocols in sub-Saharan Africa. Methods: We describe the prevalence of inadequate virological response (IVR) to ART (viral load ≥ 500 copies/mL) and identify factors associated with this outcome in 606 HIV-positive patients treated for at least 6 months. Recruitment took place in 7 hospitals and community-based sites in Bamako and Ouagadougou, and information was collected using medical charts and interviews. Results: The overall prevalence of IVR in treatment-naive patients was 12.3% and 24.4% for pretreated patients. There were no differences in rates of IVR according to ART delivery sites and time on treatment. Patients living farther away [odds ratio (OR) = 2.48; 95% confidence interval (CI) 1.40 to 4.39], those on protease inhibitor or nucleoside reverse transcriptase inhibitor regimens (OR = 3.23; 95% CI 1.79 to 5.82) and those reporting treatment interruptions (OR = 2.36; 95% CI 1.35 to 4.15), had increased odds of IVR. Immune suppression (OR = 3.32, 95% CI 1.94 to 5.70) and poor self-rated health (OR = 2.00; 95% CI 1.17 to 3.41) were also associated with IVR. Conclusions: Sufficient expertise and dedication exist in public hospital and community-based programs to achieve rates of treatment success comparable to better-resourced settings.</div>
</front>
</TEI>
<affiliations><list><country><li>Burkina Faso</li>
<li>Canada</li>
<li>Mali</li>
</country>
<region><li>Québec</li>
</region>
<settlement><li>Montréal</li>
</settlement>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Boileau, Catherine" sort="Boileau, Catherine" uniqKey="Boileau C" first="Catherine" last="Boileau">Catherine Boileau</name>
</noRegion>
<name sortKey="Chamberland, Annie" sort="Chamberland, Annie" uniqKey="Chamberland A" first="Annie" last="Chamberland">Annie Chamberland</name>
<name sortKey="Machouf, Nima" sort="Machouf, Nima" uniqKey="Machouf N" first="Nima" last="Machouf">Nima Machouf</name>
<name sortKey="Nguyen, Vinh Kim" sort="Nguyen, Vinh Kim" uniqKey="Nguyen V" first="Vinh-Kim" last="Nguyen">Vinh-Kim Nguyen</name>
<name sortKey="Rashed, Selim" sort="Rashed, Selim" uniqKey="Rashed S" first="Sélim" last="Rashed">Sélim Rashed</name>
<name sortKey="Sylla, Mohamed" sort="Sylla, Mohamed" uniqKey="Sylla M" first="Mohamed" last="Sylla">Mohamed Sylla</name>
<name sortKey="Tremblay, Cecile" sort="Tremblay, Cecile" uniqKey="Tremblay C" first="Cécile" last="Tremblay">Cécile Tremblay</name>
</country>
<country name="Mali"><noRegion><name sortKey="Traore, Hamar A" sort="Traore, Hamar A" uniqKey="Traore H" first="Hamar A." last="Traore">Hamar A. Traore</name>
</noRegion>
<name sortKey="Cisse, Mamadou" sort="Cisse, Mamadou" uniqKey="Cisse M" first="Mamadou" last="Cisse">Mamadou Cisse</name>
<name sortKey="Maiga, Moussa" sort="Maiga, Moussa" uniqKey="Maiga M" first="Moussa" last="Maiga">Moussa Maiga</name>
</country>
<country name="Burkina Faso"><noRegion><name sortKey="Niamba, Pascal A" sort="Niamba, Pascal A" uniqKey="Niamba P" first="Pascal A." last="Niamba">Pascal A. Niamba</name>
</noRegion>
<name sortKey="Diallo, Ismael" sort="Diallo, Ismael" uniqKey="Diallo I" first="Ismaël" last="Diallo">Ismaël Diallo</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006348 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006348 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:08-0387823
   |texte=   Low Prevalence of Detectable HIV Plasma Viremia in Patients Treated With Antiretroviral Therapy in Burkina Faso and Mali
}}

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024

	Le SIDA en Afrique subsaharienne (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Le SIDA en Afrique subsaharienne (serveur d'exploration)

Low Prevalence of Detectable HIV Plasma Viremia in Patients Treated With Antiretroviral Therapy in Burkina Faso and Mali

Low Prevalence of Detectable HIV Plasma Viremia in Patients Treated With Antiretroviral Therapy in Burkina Faso and Mali

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri